Pages Below:
| |
HIV And AIDS
- World-wide estimation 30-40 million people infected by 2000
- Following inoculation of a naïve host with biological fluid (blood, blood
products or sexual secretions) containing HIV-1, the virus adheres to cells
expressing CD4 and its coreceptor CCR5 and enters cell
- HIV produces its own DNA from RNA which is incorporated into host DNA and
replicated
- This process allows several therapeutic targets
- Entry of virus into cell via CD4/CCR5 receptor combination
- HIV-DNA polymerase (reverse transcriptase)
- The integrase enzyme
- The transactivator of transcription (tat) protein that accelerates
replication viral RNA
- HIV-1 protease
- Newly formed HIV-1 Virons infect CD4/CCR5-+ cells and subsequently impair
host immune response by killing/inhibiting CD4/CCR5-+ cells therefore
individual at high risk of opportunistic infection
Aetiology
- HIV infection →
- progressive fall in CD4 T-helper cell
- failure of T-cell proliferation after stimulation
- AIDS
AIDS Definition
- progressive immunodeficiency without another cause manifested by
- opportunistic infections
- Tumours
- Kaposi's sarcoma
- Non T-Cell lymphoma
- Neurological manifestations
- progressive multifocal leukoencephalopathy
Epidemiology
- estimated 30-40 million HIV infected worldwide
Transmission
- (N. America, Western Europe, UK)
- IV drug users
- Homosexual activity
- (Sub-saharan africa, Asia)
- heterosexual activity
- infected blood products
HIV life-cycle
- CD4 / CCR5 expressing cells invaded
- HIV produces DNA from RNA (reverse transcriptase)
- DNA incorporated into host genome and replicate
- 10.3 x 109virions produced each day
- mean time for generation 2.6 days
Symptoms and Signs
- seroconversion illness
- meningism
- skin rash
- temperature
- lymphadenopathy
- Pre-AIDS
- AIDS
Complications
Investigations
- HIV serology
- Antibody positive within 3 months of infection
- CD4 count
- normal 800x106 / L
- if <200 then risk of opportunistic infections
- HIV p24 antigen
- implies active replication
- poor prognosis
Treatment
Aim
- Maximal suppression of HIV replication for as long as possible
Recommended guidelines
- Treat before significant immunosuppression occurs
- Treament criteria
- HIV RNA copies if 5000-10 000/ml or more
- or CD4 count <500
- or symptoms
- Combination therapy used
- Standard care
- 2 nucleoside analogue RT inhibitors + protease inhibitor
- 2 NRTIs + 1 NNRTI
- Treatment failure/resistance change 2 or all 3 drugs
|